Vascular endothelial growth factor +936C/T, -634G/C, -2578C/A, and -1154G/A polymorphisms with risk of preeclampsia: A meta-analysis

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Cheng, Daye ^a   Hao, Yiwen ^a   Zhou, Wenling ^a   Ma, Yiran ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN;

ARTICLE; CASE CONTROL STUDY; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; HUMAN; PREECLAMPSIA; QUANTITATIVE ANALYSIS; RISK ASSESSMENT; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMATIC REVIEW; VEGF GENE;

3' UNTRANSLATED REGIONS; 5' UNTRANSLATED REGIONS; DATABASES, BIBLIOGRAPHIC; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; PRE-ECLAMPSIA; PREGNANCY; RISK; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84892607567     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0078173     Document Type: Article

References (37)

1. Ghulmiyyah L, Sibai B (2012) Maternal mortality from preeclampsia/ eclampsia. Semin Perinatol 36: 56-59.
2. Moodley J (2004) Maternal deaths associated with hypertensive disorders of pregnancy: a population-based study. Hypertens Pregnancy 23: 247-256.
3. Eiland E, Nzerue C, Faulkner M (2012) Preeclampsia 2012. J Pregnancy 2012: 586578.
4. Sibai BM (2003) Diagnosis and management of gestational hypertension and preeclampsia. Obstet Gynecol 102: 181-192.
5. Atis A, Oruc O, Aydin Y, Cetincelik U, Goker N (2012) Vascular endothelial growth factor gene +813CC polymorphism of foetus is associated with preterm labour but not with pre-eclampsia in Turkish pregnant women. Int J Immunogenet 39: 241-246.
6. Ferrara N, Davis-Smyth T (1997) The biology of vascular endothelial growth factor. Endocr Rev 18: 4-25.
7. Ong S, Lash G, Baker PN (2000) Angiogenesis and placental growth in normal and compromised pregnancies. Baillieres Best Pract Res Clin Obstet Gynaecol 14: 969-980.
8. Baker PN, Krasnow J, Roberts JM, Yeo KT (1995) Elevated serum levels of vascular endothelial growth factor in patients with preeclampsia. Obstet Gynecol 86: 815-821.
9. Sharkey AM, Cooper JC, Balmforth JR, McLaren J, Clark DE, et al. (1996) Maternal plasma levels of vascular endothelial growth factor in normotensive pregnancies and in pregnancies complicated by pre-eclampsia. Eur J Clin Invest 26: 1182-1185.
10. Brockelsby J, Hayman R, Ahmed A, Warren A, Johnson I, et al. (1999) VEGF via VEGF receptor-1 (Flt-1) mimics preeclamptic plasma in inhibiting uterine blood vessel relaxation in pregnancy: implications in the pathogenesis of preeclampsia. Lab Invest 79: 1101-1111.
11. Brownbill P, Mills TA, Soydemir DF, Sibley CP (2008) Vasoactivity to and endogenous release of vascular endothelial growth factor in the in vitro perfused human placental lobule from pregnancies complicated by preeclampsia. Placenta 29: 950-955.
12. Foidart JM, Schaaps JP, Chantraine F, Munaut C, Lorquet S (2009) Dysregulation of anti-angiogenic agents (sFlt-1, PLGF, and sEndoglin) in preeclampsia-a step forward but not the definitive answer. J Reprod Immunol 82: 106-111.
13. Reuvekamp A, Velsing-Aarts FV, Poulina IE, Capello JJ, Duits AJ (1999) Selective deficit of angiogenic growth factors characterises pregnancies complicated by pre-eclampsia. Br J Obstet Gynaecol 106: 1019-1022.
14. Lyall F, Greer IA, Boswell F, Fleming R (1997) Suppression of serum vascular endothelial growth factor immunoreactivity in normal pregnancy and in preeclampsia. Br J Obstet Gynaecol 104: 223-228.
15. Anthony FW, Evans PW, Wheeler T, Wood PJ (1997) Variation in detection of VEGF in maternal serum by immunoassay and the possible influence of binding proteins. Ann Clin Biochem 34 (Pt 3): 276-280.
16. Bosio PM, Wheeler T, Anthony F, Conroy R, O'Herlihy C, et al. (2001) Maternal plasma vascular endothelial growth factor concentrations in normal and hypertensive pregnancies and their relationship to peripheral vascular resistance. Am J Obstet Gynecol 184: 146-152.
17. Hunter A, Aitkenhead M, Caldwell C, McCracken G, Wilson D, et al. (2000) Serum levels of vascular endothelial growth factor in preeclamptic and normotensive pregnancy. Hypertension 36: 965-969.
18. Andraweera PH, Dekker GA, Dissanayake VH, Bianco-Miotto T, Jayasekara RW, et al. (2013) Vascular endothelial growth factor family gene polymorphisms in preeclampsia in Sinhalese women in Sri-Lanka. J Matern Fetal Neonatal Med 26: 532-536.
19. Pasqualetti G, Danesi R, Del Tacca M, Bocci G (2007) Vascular endothelial growth factor pharmacogenetics: a new perspective for anti-angiogenic therapy. Pharmacogenomics 8: 49-66.
20. Chedraui P, Solis EJ, Bocci G, Gopal S, Russo E, et al. (2013) Feto-placental nitric oxide, asymmetric dimethylarginine and vascular endothelial growth factor (VEGF) levels and VEGF gene polymorphisms in severe preeclampsia. J Matern Fetal Neonatal Med 26: 226-232.
21. (2002) ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet 77: 67-75.
22. Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50: 1088-1101.
23. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629-634.
24. Cunha VM, Grecco RL, Paschoini MC, Silva SR, Ruiz MT, et al. (2011) [Genetic polymorphisms of vascular endothelial growth factor in pre-eclampsia]. Rev Bras Ginecol Obstet 33: 158-163.
25. Garza-Veloz I, Castruita-De la Rosa C, Cortes-Flores R, Martinez-Gaytan V, Rivera-Munoz JE, et al. (2011) No association between polymorphisms/ haplotypes of the vascular endothelial growth factor gene and preeclampsia. BMC Pregnancy Childbirth 11: 35.
26. Kim YJ, Park BH, Park H, Jung SC, Pang MG, et al. (2008) No association of the genetic polymorphisms of endothelial nitric oxide synthase, dimethylarginine dimethylaminohydrolase, and vascular endothelial growth factor with preeclampsia in Korean populations. Twin Res Hum Genet 11: 77-83.
27. Shim JY, Jun JK, Jung BK, Kim SH, Won HS, et al. (2007) Vascular endothelial growth factor gene +936 C/T polymorphism is associated with preeclampsia in Korean women. Am J Obstet Gynecol 197: 271 e271-274.
28. Banyasz I, Szabo S, Bokodi G, Vannay A, Vasarhelyi B, et al. (2006) Genetic polymorphisms of vascular endothelial growth factor in severe pre-eclampsia. Mol Hum Reprod 12: 233-236.
29. Papazoglou D, Galazios G, Koukourakis MI, Panagopoulos I, Kontomanolis EN, et al. (2004) Vascular endothelial growth factor gene polymorphisms and pre-eclampsia. Mol Hum Reprod 10: 321-324.
30. Sandrim VC, Palei AC, Cavalli RC, Araujo FM, Ramos ES, et al. (2009) Vascular endothelial growth factor genotypes and haplotypes are associated with pre-eclampsia but not with gestational hypertension. Mol Hum Reprod 15: 115-120.
31. Huang Y, Liu J (2009) Analysis on gene polymorphism of vascular endothelial growth factor and susceptibility of preeclampsia patients. Matern Child Health Care China 24: 2712-2713.
32. Yun H (2011) A study of the association about VEGF gene polymorphisms, sFIt-1, PIGF with preeclampsia. Nanfang Medical University.
33. Renner W, Kotschan S, Hoffmann C, Obermayer-Pietsch B, Pilger E (2000) A common 936 C/T mutation in the gene for vascular endothelial growth factor is associated with vascular endothelial growth factor plasma levels. J Vasc Res 37: 443-448.
34. Stevens A, Soden J, Brenchley PE, Ralph S, Ray DW (2003) Haplotype analysis of the polymorphic human vascular endothelial growth factor gene promoter. Cancer Res 63: 812-816.
35. Jain L, Vargo CA, Danesi R, Sissung TM, Price DK, et al. (2009) The role of vascular endothelial growth factor SNPs as predictive and prognostic markers for major solid tumors. Mol Cancer Ther 8: 2496-2508.
36. Livingston JC, Chin R, Haddad B, McKinney ET, Ahokas R, et al. (2000) Reductions of vascular endothelial growth factor and placental growth factor concentrations in severe preeclampsia. Am J Obstet Gynecol 183: 1554-1557.
37. Madazli R, Aydin S, Uludag S, Vildan O, Tolun N (2003) Maternal plasma levels of cytokines in normal and preeclamptic pregnancies and their relationship with diastolic blood pressure and fibronectin levels. Acta Obstet Gynecol Scand 82: 797-802.